CTS successfully implemented Donor-Screen HLA® Class I and II testing on the Stratec Biomedical AG Gemini on Monday, April 29th. As previously communicated, the Immucor assay and sample requirements are the same, and the package insert has been modified to state the assay is specific to the Stratec Gemini instrument. The new package insert, assay history list, and platform history list are now available on our website.
Reminder: On Wednesday August 15, 2018 at 11:00AM PDT, we will be hosting a webinar regarding the ch...
The FDA Guidance ZIKV video for the webinar held on 08/15/18 has been posted in the Wh...
National Blood Donor Month has been observed in January since 1970, with the goal of increasing bloo...
IPFA welcomes Marion Lanteri as Executive Board member, CTS as new member organization
In response to the FDA guidance document for Babesia, CTS will implement the licensed Grifols ...
CTS will implement the Bio-Rad Geenius HIV 1/2 supplemental assay on Monday September 21, 2020. The ...